logo

For the Inventor, By the Inventor

Berlin, Germany

Karsten Parczyk

This inventor holds 12 USPTO granted patents. Top assignees: Schering Aktiengesellschaft, Bayer Schering Pharma Ag. Active years: 1998-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karsten Parczyk. Retrieved from https://idiyas.com/inventor/karsten-parczyk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 66.7

Average Co-Inventor Count = 7.5

ph-index = 5

Forward Citations = 75(Granted Patents)


Company Filing History:

goldMedal11 out of 1,409 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 192 
 
Bayer Schering Pharma Ag
 patents

Years Active: 1998-2009

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7601748 - Anti-androgenic pyrrolidines with tumor-inhibiting action (2009-10-13),
2. 7138421 - Anti-androgenic pyrrolidines with tumor-inhibiting action (2006-11-21),
3. 7074829 - Antiestrogens, process for their production and their pharmaceutical use (2006-07-11),
4. 6780855 - 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS (2004-08-24),
5. 6767903 - New7&agr;, 17&agr;-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases (2004-07-27),
6. 6559181 - Antiestrogens, process for their protection and their pharmaceutical use (2003-05-06),
7. 6288051 - 7 &agr;-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 &agr;(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents (2001-09-11),
8. 6271403 - 7&agr;-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7&agr;-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents (2001-08-07),
9. 6166075 - Antiestrogens, process for their production and their pharmaceutical use (2000-12-26),
10. 5986115 - 7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, (1999-11-16),
11. 5866560 - 7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, (1999-02-02),
12. 5807899 - Triphenylethylenes, process for their production, pharmaceutical (1998-09-15),

Certainly! Here is the article about inventor Karsten Parczyk:

Title: Unveiling the Innovations of Karsten Parczyk in Berlin

Introduction:

Karsten Parczyk, a distinguished inventor based in Berlin, Germany, has made significant contributions to the field of pharmaceuticals with a total of 12 patents under his name. His groundbreaking work has revolutionized the landscape of anti-androgenic compounds with tumor-inhibiting properties.

Latest Patents:

Among his latest patents is the invention of Anti-androgenic pyrrolidines with tumor-inhibiting action. This breakthrough pertains to the development of anti-androgenic pyrrolidines that display a robust antiproliferative profile, offering new possibilities in the realm of cancer treatment. The patented formula I showcases his innovative approach towards pharmaceutical advancements.

Career Highlights:

Karsten Parczyk has harnessed his expertise while working at esteemed companies such as Schering Aktiengesellschaft and Bayer Schering Pharma AG. His tenure at these renowned institutions has been marked by a commitment to excellence and a passion for driving cutting-edge research in the pharmaceutical sector.

Collaborations:

Throughout his career, Karsten Parczyk has collaborated with notable professionals in the field, including visionary individuals like Rolf Bohlmann and Rosemarie Lichtner. These collaborations have fostered a culture of innovation, leading to the development of groundbreaking solutions that have the potential to transform the medical industry.

Conclusion:

In conclusion, Karsten Parczyk's relentless pursuit of innovation and his invaluable contributions to the field of pharmaceuticals have solidified his position as a trailblazer in the scientific community. His patents and inventions stand as a testament to his unwavering dedication to pushing the boundaries of what is possible in the realm of cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…